The results showed a similar tendency (r = −0.82, P < 0.01), and patients with lymph node metastases also showed lower expression of RRAD along with higher expression levels of GLUT3 (Supplementary Fig. 7A, B). This evidence concerns the gene RRAD and metastatic malignant neoplasm in the lymph nodes.